Decrease of anti-Mullerian hormone in genetic spermatogenic failure

Andrologia. 2012 Oct;44(5):349-54. doi: 10.1111/j.1439-0272.2010.01092.x. Epub 2011 Mar 25.

Abstract

The aim of this study was to compare anti-Mullerian hormone (AMH) plasma levels in patients with azoospermia according to the physiopathology. In a prospective clinical study from April 2008 to March 2009 in University Hospital, we measured AMH levels in 49 consecutive patients with azoospermia. AMH plasma levels were correlated with FSH, inhibin B, bioavailable testosterone plasma levels and testicular volume and compared between nonobstructive azoospermia (NOA) and obstructive azoospermia (OA) and within four physiopathological subgroups of NOA: genetic, cryptorchidism, cytotoxic and unexplained. AMH, FSH, inhibin B, bioavailable testosterone plasma levels and testicular volumes were all related to each other. AMH plasma levels were lower in NOA relatively to OA. Lowest values were observed in cases of genetic NOA and on the other hand, the values observed in case of cytotoxic NOA were as high as the values observed in OA. FSH, inhibin B, bioavailable testosterone and testicular volume were not different between genetic and cytotoxic NOA. These results suggest that the decrease in AMH plasma levels is related to the origin of NOA, with low values in genetic NOA and values similar to OA in cytotoxic NOA. Further studies will be useful to understand the fine regulation of AMH production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Mullerian Hormone / blood*
  • Azoospermia / blood*
  • Azoospermia / etiology
  • Azoospermia / genetics
  • Cryptorchidism / blood
  • Follicle Stimulating Hormone / blood
  • Humans
  • Inhibins / blood
  • Male
  • Middle Aged
  • Prospective Studies
  • Spermatogenesis / genetics*
  • Testis / anatomy & histology
  • Testosterone / blood

Substances

  • inhibin B
  • Testosterone
  • Inhibins
  • Anti-Mullerian Hormone
  • Follicle Stimulating Hormone